FDA Warning Letter Brings Another High-Flying Emergent CDMO Plant Down To Earth

 
• By Bowman Cox

Warning letter reveals agency found quality problems at Emergent BioSolutions’ Camden fill/finish plant during COVID-19 pandemic even as firm’s Bayview plant came under heightened scrutiny. Metal particulates appeared in vials as Camden plant and rest of Emergent’s CDMO network experienced sharp demand growth.

Filling vials
metal particulates began showing up in vials as demand spiked • Source: Shutterstock

More from Manufacturing

More from Compliance